Kirk R. Schultz

1990–2025 年に発表

110
論文数
18,242
被引用数
66
h 指数
105
i10 指数

被引用数

Kirk R. Schultz の年別被引用数1991 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 4 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 8 件2002 年: 被引用 6 件2003 年: 被引用 16 件2004 年: 被引用 9 件2005 年: 被引用 12 件2006 年: 被引用 48 件2007 年: 被引用 40 件2008 年: 被引用 82 件2009 年: 被引用 87 件2010 年: 被引用 107 件2011 年: 被引用 112 件2012 年: 被引用 124 件2013 年: 被引用 103 件2014 年: 被引用 110 件2015 年: 被引用 164 件2016 年: 被引用 134 件2017 年: 被引用 147 件2018 年: 被引用 124 件2019 年: 被引用 454 件2020 年: 被引用 605 件2021 年: 被引用 575 件2022 年: 被引用 480 件2023 年: 被引用 316 件2024 年: 被引用 606 件2025 年: 被引用 225 件1992 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,712 件、この内訳の 25.4%ドイツ: 引用元論文 489 件、この内訳の 7.2%イギリス: 引用元論文 398 件、この内訳の 5.9%イタリア: 引用元論文 374 件、この内訳の 5.5%フランス: 引用元論文 369 件、この内訳の 5.5%カナダ: 引用元論文 316 件、この内訳の 4.7%中国: 引用元論文 283 件、この内訳の 4.2%オランダ: 引用元論文 277 件、この内訳の 4.1%スペイン: 引用元論文 213 件、この内訳の 3.2%スイス: 引用元論文 182 件、この内訳の 2.7%日本: 引用元論文 175 件、この内訳の 2.6%オーストラリア: 引用元論文 172 件、この内訳の 2.5%
0%25.4%その他 26.5%

分野

  • Medicine83.5%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology6.5%
  • Health Professions0.3%
  • Neuroscience0.2%
  • Dentistry0.2%
  • その他1.1%

トピック

  • Hematopoietic Stem Cell Transplantation16.7%
  • Acute Lymphoblastic Leukemia research9.6%
  • Acute Myeloid Leukemia Research6.4%
  • Immune Cell Function and Interaction4.3%
  • T-cell and B-cell Immunology4%
  • Childhood Cancer Survivors' Quality of Life3.9%
  • その他55.1%

共著者

全論文

検索で開く
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2005 被引用: 3,530

  2. Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Jacobsohn, Nahal Lalefar, Maxim Norkin, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrović, Kirk R. Schultz, Gregory A. Yanik, Edmund K. Waller, John E. Levine, James L.M. Ferrara, Bruce R. Blazar, Amelia Langston, John Horan, Leslie S. Kean - Journal of Clinical Oncology 2021 被引用: 249

  3. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

    著者: , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 被引用: 491

  4. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 419

  5. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 被引用: 435

  6. Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adriana Balduzzi, on behalf of the I-BFM SCT Study Group, Selim Corbacioglu, on behalf of the EBMT Paediatric Diseases Working Party, Peter Bader - Journal of Clinical Oncology 2020 被引用: 329

  7. The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    著者: , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2016 被引用: 456

  8. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hildegard Greinix, Stefanie Sarantopoulos, Gèrard Socié, Bruce R. Blazar, Joseph Pidala, Carrie L. Kitko, Daniel R. Couriel, Corey Cutler, Kirk R. Schultz, Steven Z. Pavletic, Stephanie J. Lee, Sophie Paczesny - Transplantation and Cellular Therapy 2021 被引用: 143

  9. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 363

  10. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation and Cellular Therapy 2021 被引用: 167

  11. Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 255

  12. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Robinson, Michael E. Ward, Bryce B. Reeve, Lisa G. Rider, Howard M. Shulman, Kirk R. Schultz, Daniel Weisdorf, Georgia B. Vogelsang - Biology of Blood and Marrow Transplantation 2006 被引用: 565

  13. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2014 被引用: 449

  14. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 被引用: 280

  15. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 250

  16. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nasheed Hossain, Christopher G. Kanakry, Mohamed A. Kharfan‐Dabaja, Nandita Khera, Yener Koç, Hillard M. Lazarus, Jong Wook Lee, Johan Maertens, Rodrigo Martino, Joseph P. McGuirk, Reinhold Munker, Hemant S. Murthy, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Neil Palmisiano, Sagar S. Patel, Joseph Pidala, Rebecca L. Olin, Richard F. Olsson, Betül Oran, Olle Ringdén, David A. Rizzieri, Jacob M. Rowe, Mary Lynn Savoie, Kirk R. Schultz, Sachiko Seo, Brian C. Shaffer, Anurag K. Singh, Melhem Solh, Keith Stockerl‐Goldstein, Leo F. Verdonck, John L. Wagner, Edmund K. Waller, Marcos de Lima, Brenda M. Sandmaier, Mark R. Litzow, Dan Weisdorf, Rizwan Romee, Wael Saber - Blood Advances 2019 被引用: 128

  17. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 315

  18. Exome Sequencing and the Management of Neurometabolic Disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseye A. Ogunbayo, Bojana Rakić, Jacob Rozmus, Peter C. Ruben, Bryan Sayson, Saikat Santra, Kirk R. Schultz, Kathryn Selby, Paul Shekel, Sandra Sirrs, Cristina Skrypnyk, Andrea Superti‐Furga, Stuart E. Turvey, Margot I. Van Allen, David S. Wishart, Jiang Wu, John K. Wu, Dimitrios Zafeiriou, Leo A. J. Kluijtmans, Ron A. Wevers, Patrice Eydoux, Anna Lehman, Hilary Vallance, Sylvia Stöckler‐Ipsiroglu, Graham Sinclair, Wyeth W. Wasserman, Clara D.M. van Karnebeek - New England Journal of Medicine 2016 被引用: 280

  19. IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients

    著者: , , , , , , , , , , , , - Blood 2015 被引用: 224

  20. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 被引用: 96

  21. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bipin N. Savani, Kirk R. Schultz, Sachiko Seo, Takanori Teshima, Marjolein van der Poel, Leo F. Verdonck, Daniel Weisdorf, Baldeep Wirk, Jean A. Yared, Jeffrey Schriber, Richard E. Champlin, Stefan O. Ciurea - Transplantation and Cellular Therapy 2022 被引用: 32

  22. Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2023 被引用: 39

  23. Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2006 被引用: 484

  24. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 232